Jpmorgan Chase & CO Dario Health Corp. Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
A detailed history of Jpmorgan Chase & CO transactions in Dario Health Corp. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 11 shares of DRIO stock, worth $8. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11
Previous 11
-0.0%
Holding current value
$8
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding DRIO
# of Institutions
35Shares Held
7.99MCall Options Held
104KPut Options Held
5.6K-
Nantahala Capital Management, LLC New Canaan, CT2.5MShares$1.85 Million0.17% of portfolio
-
Appian Way Asset Management LP New York, NY1.41MShares$1.04 Million0.36% of portfolio
-
Phoenix Holdings Ltd. Givatayim, L31.13MShares$833,7840.02% of portfolio
-
Y.D. More Investments LTD Ramat Gan, L3754KShares$557,7980.09% of portfolio
-
Clal Insurance Enterprises Holdings LTD Tel Aviv, L3512KShares$379,0090.01% of portfolio
About DarioHealth Corp.
- Ticker DRIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 23,295,000
- Market Cap $17.2M
- Description
- DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand. The company offers Dario's metabolic solutions to address metabolic health needs, such as diabetes, hypertension, and weight management; Dario Musculoskeletal, which helps to prevent and treat the most common...